Clinical Trial

Biomarker Profiling in Abdominal Aortic Aneurysm Patients

Study acronym: BIOMArCS-AAA
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 16, 2024 (before its estimated August 2024 completion). Its status may not reflect the trial's current state.
Summary
The BIOMArCS-AAA study aims to investigate the associations of (temporal patterns of) blood biomarkers with aneurysm growth in patients with abdominal aortic aneurysm (AAA), with particular attention to biomarkers that have demonstrated prognostic value for adverse disease outcomes in coronary artery disease and biomarkers for the main genetic pathways associated with AAA.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT03703947
Lead Sponsor Erasmus Medical Center
Collaborators: Maasstad Hospital
Conditions Abdominal Aortic Aneurysm
Enrollment 440 participants
Start Date 2017-03-23
Primary Completion 2024-08 (estimated)
Study Completion 2024-08 (estimated)
Updated on ClinicalTrials.gov 2024-07-16